• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

端粒处于衰老、肿瘤抑制和炎症的交汇点:迈向超越细胞衰老的理解。

Telomeres at the nexus of aging, tumor suppression, and inflammation: toward an understanding beyond senescence.

作者信息

Bloom Samuel I, Karlseder Jan

机构信息

The Salk Institute for Biological Studies, La Jolla, California 92037, USA.

The Salk Institute for Biological Studies, La Jolla, California 92037, USA

出版信息

Genes Dev. 2025 Aug 1;39(15-16):920-922. doi: 10.1101/gad.353122.125.

DOI:10.1101/gad.353122.125
PMID:40645667
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12315855/
Abstract

Aging is the greatest risk factor for most diseases. We propose that aging manifests as disease as a function of tumor-suppressive capabilities. Adequate tumor suppression results in cell death or an accumulation of damaged cells leading to inflammation and tissue dysfunction that underlies diseases such as cardiovascular disease, neurodegenerative diseases, or type 2 diabetes. Conversely, inadequate tumor suppression leads to cancer. Telomeres are central to this process because they oppose hyperproliferation that is required for cancer initiation by enforcing two potent tumor suppressor mechanisms: senescence and crisis. Although senescent cells promote age-related diseases via inflammatory signaling, crisis cells have lost the p53 and RB pathways, have more unstable genomes, and harbor shorter telomeres, all of which could increase inflammation to a greater degree than is seen in senescence. This model emphasizes the intimate relationship between aging, telomeres, tumor suppression, and inflammation and suggests that crisis cells may represent an unexplored driver of inflammation in advanced age.

摘要

衰老是大多数疾病的最大风险因素。我们提出,衰老作为一种疾病表现,是肿瘤抑制能力的函数。充分的肿瘤抑制会导致细胞死亡或受损细胞的积累,从而引发炎症和组织功能障碍,而这正是心血管疾病、神经退行性疾病或2型糖尿病等疾病的基础。相反,肿瘤抑制不足会导致癌症。端粒在这个过程中至关重要,因为它们通过强化两种强大的肿瘤抑制机制——衰老和危机,来对抗癌症起始所需的过度增殖。虽然衰老细胞通过炎症信号促进与年龄相关的疾病,但处于危机状态的细胞已经失去了p53和RB通路,基因组更不稳定,端粒更短,所有这些都可能比衰老状态下引发更严重的炎症。该模型强调了衰老、端粒、肿瘤抑制和炎症之间的密切关系,并表明处于危机状态的细胞可能是老年炎症未被探索的驱动因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8b2/12315855/ded8e497e7f5/920f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8b2/12315855/ded8e497e7f5/920f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8b2/12315855/ded8e497e7f5/920f01.jpg

相似文献

1
Telomeres at the nexus of aging, tumor suppression, and inflammation: toward an understanding beyond senescence.端粒处于衰老、肿瘤抑制和炎症的交汇点:迈向超越细胞衰老的理解。
Genes Dev. 2025 Aug 1;39(15-16):920-922. doi: 10.1101/gad.353122.125.
2
Sexual Harassment and Prevention Training性骚扰与预防培训
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
Short-Term Memory Impairment短期记忆障碍
5
Citrullinemia Type II型瓜氨酸血症
6
Molecular and Environmental Modulators of Aging: Interplay Between Inflammation, Epigenetics, and RNA Stability.衰老的分子与环境调节因子:炎症、表观遗传学和RNA稳定性之间的相互作用
Genes (Basel). 2025 Jul 1;16(7):796. doi: 10.3390/genes16070796.
7
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.降低男男性行为者中艾滋病毒性传播风险的行为干预措施。
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
8
Systemic Inflammatory Response Syndrome全身炎症反应综合征
9
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

本文引用的文献

1
p53 enhances DNA repair and suppresses cytoplasmic chromatin fragments and inflammation in senescent cells.p53可增强DNA修复,并抑制衰老细胞中的细胞质染色质片段及炎症反应。
Nat Commun. 2025 Mar 5;16(1):2229. doi: 10.1038/s41467-025-57229-3.
2
Telomere function and regulation from mouse models to human ageing and disease.从小鼠模型到人类衰老与疾病的端粒功能及调控
Nat Rev Mol Cell Biol. 2025 Apr;26(4):297-313. doi: 10.1038/s41580-024-00800-5. Epub 2024 Nov 29.
3
Telomeres as hotspots for innate immunity and inflammation.端粒作为先天免疫和炎症的热点。
DNA Repair (Amst). 2024 Jan;133:103591. doi: 10.1016/j.dnarep.2023.103591. Epub 2023 Nov 5.
4
Telomere-to-mitochondria signalling by ZBP1 mediates replicative crisis.ZBP1 通过端粒到线粒体信号传导介导复制危机。
Nature. 2023 Feb;614(7949):767-773. doi: 10.1038/s41586-023-05710-8. Epub 2023 Feb 8.
5
Autophagic cell death restricts chromosomal instability during replicative crisis.自噬性细胞死亡限制复制危机期间的染色体不稳定性。
Nature. 2019 Jan;565(7741):659-663. doi: 10.1038/s41586-019-0885-0. Epub 2019 Jan 23.
6
Review: a meta-analysis of GWAS and age-associated diseases.综述:GWAS 与年龄相关疾病的荟萃分析。
Aging Cell. 2012 Oct;11(5):727-31. doi: 10.1111/j.1474-9726.2012.00871.x. Epub 2012 Aug 30.
7
Pathobiology of aging mice and GEM: background strains and experimental design.衰老小鼠和 GEM 的病理生物学:背景品系和实验设计。
Vet Pathol. 2012 Jan;49(1):85-105. doi: 10.1177/0300985811430696.
8
Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor.衰老相关分泌表型揭示了致癌RAS和p53肿瘤抑制因子的细胞非自主功能。
PLoS Biol. 2008 Dec 2;6(12):2853-68. doi: 10.1371/journal.pbio.0060301.
9
Linkage and association study of late-onset Alzheimer disease families linked to 9p21.3.与9p21.3相关的晚发性阿尔茨海默病家族的连锁与关联研究。
Ann Hum Genet. 2008 Nov;72(Pt 6):725-31. doi: 10.1111/j.1469-1809.2008.00474.x. Epub 2008 Aug 28.
10
Species- and cell type-specific requirements for cellular transformation.细胞转化的物种和细胞类型特异性要求。
Cancer Cell. 2004 Aug;6(2):171-83. doi: 10.1016/j.ccr.2004.07.009.